Medscape published a report on research by Ambria Moten, MD, MS, Surgery Resident at Temple University Hospital, and colleagues, that found that about a quarter of all patients with low-risk thyroid cancer are still receiving radioactive iodine (RAI) therapy despite recommendations against its use in the patient population. The research was published in the June issue of Surgical Oncology.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH